LEO PHARMA HOLDING LIMITED

Leo Pharma Holding Limited is a specialist pharmaceutical company dedicated to medical dermatology. With more than 60 years of manufacturing expertise, the group develops and supplies prescription treatments that help people achieve healthy skin and manage conditions such as psoriasis, eczema and other immune-mediated skin disorders.

Headquartered in Denmark, Leo Pharma employs around 6,000 professionals across 60 countries and distributes its products to patients in over 130 nations. In the UK and Ireland, the company supports clinicians and patients with a transparent approach to clinical trials, providing clear information on study results so that treatment decisions are well-informed.

Guided by a mission to improve the lives of those living with dermatological conditions, Leo Pharma aims to positively impact 125 million lives by 2025. Its focus on research, patient-centred care and continual reinvestment of knowledge positions it as a trusted partner for healthcare professionals seeking effective, science-backed skin therapies.